Skip to main content
Top

Reviews in Endocrine and Metabolic Disorders

Issue 1-2/2006

Special issue on Osteoporosis

Content (12 Articles)

Networks and hubs for the transcriptional control of osteoblastogenesis

Jane B. Lian, Gary S. Stein, Amjad Javed, Andre J. van Wijnen, Janet L. Stein, Martin Montecino, Mohammad Q. Hassan, Tripti Gaur, Christopher J. Lengner, Daniel W. Young

Wnt signaling and osteoblastogenesis

Peter V. N. Bodine, Barry S. Komm

Diseases of Wnt signaling

Mark L. Johnson, Nalini Rajamannan

Bone morphogenetic proteins and their antagonists

Elisabetta Gazzerro, Ernesto Canalis

New imaging technologies in the diagnosis of osteoporosis

Galateia J. Kazakia, Sharmila Majumdar

Anorexia nervosa and osteoporosis

Madhusmita Misra, Anne Klibanski

The use of parathyroid hormone in the treatment of osteoporosis

Monica Girotra, Mishaela R. Rubin, John P. Bilezikian

Molecular regulation of osteoclast activity

Angela Bruzzaniti, Roland Baron

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine